Proto Labs Inc
No SEC Form 4 filings for $PRLB in the last 30 days.
See all $PRLB insider activity →Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.
Simply Wall St reports Proto Labs (PRLB) updated its full-year outlook after its Q2 2026 results and an employee stock offering announced 31 July 2026. The article cites a raised 2026 revenue growth outlook, with revenue per customer up 11% y/y and cross-platform adoption up 44% y/y. It sets fair value at $88 versus a $88.91 close.
Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.
Over the past 7 days, alphai's AI scored 1 news story mentioning PRLB (Proto Labs Inc). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent PRLB coverage spans earnings, financial news and insider activity.
Guidance raise plus margin expansion and zero-debt balance are likely to support near-term sentiment, while Europe profitability remains a stated execution risk.
The article frames PRLB as having improved growth and earnings quality, but still facing margin risk from aerospace and defense concentration and weaker European manufacturing.
Guidance and margin expansion suggest improving profitability and demand mix, with Europe still flagged as a mid- to long-term transformation.
Overall demand looks healthy, but AM revenue was essentially flat, which may limit upside versus pure-play AM narratives.
The earnings call content provides fresh Q2 results plus explicit Q3 revenue and EPS guidance, supporting a near-term re-rate if investors buy the margin and customer-relationship narrative.
alphai scores every news story that mentions PRLB with an AI model for sentiment and relevance, and aggregates insider trades from Proto Labs Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.
Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.
6 min readSimply Wall St reports Proto Labs (PRLB) updated its full-year outlook after its Q2 2026 results and an employee stock offering announced 31 July 2026. The article cites a raised 2026 revenue growth outlook, with revenue per customer up 11% y/y and cross-platform adoption up 44% y/y. It sets fair value at $88 versus a $88.91 close.
4 min readProto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.
6 min readXometry (Nasdaq: XMTR) reported record Q revenue of $229M, up 41% YoY, and raised its full-year revenue growth forecast to 33% to 34%. Protolabs (NYSE: PRLB) posted record Q revenue of $149.3M, up 10.6%, and lifted guidance to 8% to 10% growth; AM revenue was $20.7M. Lincoln Electric (Nasdaq: LECO) reported record Q2 sales near $1.22B, up 12%.
6 min readProto Labs (PRLB) reported Q2 revenue of $149.3M vs $144.1M estimates and adjusted EPS of $0.60 vs $0.54, citing customer relationship expansion and growth in Injection Molding and CNC Machining. Management guided Q3 revenue to $149M and adjusted EPS to $0.60. Operating margin rose to 7.6%.
6 min readA roundup of Monday Wall Street analyst actions includes Jefferies upgrading Parsons to Buy, TD Cowen initiating Circle at Buy with an $82 price target, and Stifel reiterating Tesla Buy while cutting its target to $491. Other calls cover Nvidia, Applied Materials, Corning, SpaceX, Sherwin-Williams, and eBay, with multiple price targets and rating changes.
7 min readProtolabs (PRLB) shares rose about 3.3% to $77.64 after the company reported Q2 net income of $9.15 million, up from $4.43 million a year earlier, with revenue at $149.34 million. Protolabs raised its FY2026 revenue growth outlook to 8% to 10% and issued Q3 guidance of $145 million to $153 million revenue and EPS of $0.34 to $0.42.
2 min readProto Labs Inc. (PRLB) reported Q2 profit of $9.2 million, or 37 cents per share. Adjusted earnings were 60 cents per share, and revenue was $149.3 million. For the quarter ending September, the company forecast 56 to 64 cents per share. For fiscal Q3, it expects revenue of $145 million to $153 million.
2 min readProto Labs Inc (PRLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prlb-2026731xexx991.htm EX-99.1 Document Exhibit 99.1 Protolabs Reports Financial Results for the Second Quarter of 2026 Record Quarterly Revenue of $149.3 Million, a 10.6% Increase Year-Over-Year GAAP Earnings Per Share of $0.37, Non-GAAP Earnings Per Share of $0.60 Ra
5 min readWEHRWEIN SVEN sold 500 shares of Proto Labs Inc (PRLB) at $78.38 on 2026-06-02.
2 min read
